False-positive rates for the qualitative analysis of urine benzodiazepines and metabolites with the reformulated Abbott Multigent™ reagents [4]

Clinical Chemistry

Volumn 54, Issue 1, 2008, Pages 220-221

  Lum, Gifford ^a   Mushlin, Barry ^a   Farney, Linda ^a  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; MULTIGENT; REAGENT; SERTRALINE; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; DEPRESSION; DIAGNOSTIC ACCURACY; DRUG SCREENING; FALSE POSITIVE RESULT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LETTER; MEDICAL RECORD; METABOLITE; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; QUANTITATIVE ANALYSIS; SOCIAL PHOBIA; URINALYSIS;

ANTIBODIES; BENZODIAZEPINES; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 38749146272     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.097014     Document Type: Letter

References (1)

1. Lum G. Utilization and cost effectiveness of standardized testing for screening and confirmation of drugs of abuse in urine. Ann Clin Lab Sci 2002;32:387-92.